Skip Ribbon Commands
Skip to main content

​​​​​​​​​

​​

Primary Diagnosis

High Cholesterol

Study Purpose

To test the efficacy of Bempedoic Acid in patients with, or at high risk for, cardiovascular disease and who are statin intolerant.

Principal Investigator: Marcus McKenzie, MD

Trial Details

Locations: Legacy Heart Center

Sponsor: Esperion

IRB Number: 017-435

Trial Status: Enrolling

Exclusions: Adults only

Change in Care: Participating will ​change your care

Contact Information:

Alexandria Biberstein, RN
469.814.4732
Alexandria.Biberstein@BSWHealth.org

Full Protocol Title

Aspirin Dosing: A randomized, double-blind, placebo-controlled study to assess the effects of bempedoic acid (ETC-1002) on the occurrence of major cardiovascular events in patients with, or at high risk for, cardiovascular disease who are statin intolerant.

Get Detailed Infor​mation On Clinicaltrials.gov »​​​​​​​​​​​​​​​​​

​​

​​​​

​​​​​​​​​​BAYLOR SCOTT & WHITE RESEARCH ​INSTITUTE​​